↓ Skip to main content

The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice

Overview of attention for article published in BMC Cancer, January 2006
Altmetric Badge

Mentioned by

patent
1 patent

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice
Published in
BMC Cancer, January 2006
DOI 10.1186/1471-2407-6-9
Pubmed ID
Authors

Frank Michael Klenke, Martha-Maria Gebhard, Volker Ewerbeck, Amir Abdollahi, Peter E Huber, Axel Sckell

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 22%
Student > Master 4 13%
Student > Ph. D. Student 3 9%
Student > Bachelor 3 9%
Student > Doctoral Student 2 6%
Other 4 13%
Unknown 9 28%
Readers by discipline Count As %
Medicine and Dentistry 7 22%
Biochemistry, Genetics and Molecular Biology 4 13%
Agricultural and Biological Sciences 4 13%
Immunology and Microbiology 3 9%
Chemistry 2 6%
Other 3 9%
Unknown 9 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2024.
All research outputs
#8,588,963
of 25,508,813 outputs
Outputs from BMC Cancer
#2,402
of 9,010 outputs
Outputs of similar age
#44,957
of 173,206 outputs
Outputs of similar age from BMC Cancer
#7
of 16 outputs
Altmetric has tracked 25,508,813 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 9,010 research outputs from this source. They receive a mean Attention Score of 4.7. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 173,206 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.